| Literature DB >> 35941568 |
Qianrong Xie1,2, Yue Chen3, Yimei Hu4, Fanwei Zeng1, Pingxi Wang5, Lin Xu6, Jianhong Wu5, Jie Li1, Jing Zhu7, Ming Xiang8,9, Fanxin Zeng10,11.
Abstract
BACKGROUND: To develop and validate a quantitative computed tomography (QCT) based radiomics model for discriminating osteoporosis and osteopenia.Entities:
Keywords: Combined clinical-radiomic model; Osteopenia; Osteoporosis; Quantitative computed tomography
Mesh:
Year: 2022 PMID: 35941568 PMCID: PMC9358842 DOI: 10.1186/s12880-022-00868-5
Source DB: PubMed Journal: BMC Med Imaging ISSN: 1471-2342 Impact factor: 2.795
Fig. 1Flowchart of this study
Fig. 2Flowchart of the radiomics method
Characteristics of Patients in the Training and Test Cohorts
| Characteristics | Training cohorts | Test cohorts | ||||
|---|---|---|---|---|---|---|
| Osteoporosis | Osteopenia | Osteoporosis | Osteopenia | |||
| Gender, No. (%) | 0.032* | 0.897 | ||||
| Male | 86 (28.40) | 20 (18.00) | 29 (22.50) | 11 (23.40) | ||
| Female | 217 (71.60) | 91 (82.00) | 100 (77.50) | 36 (76.60) | ||
| Age, mean (SE), years | 70.03 (0.55) | 58.32 (0.92) | < 0.001* | 69.11 (0.85) | 57.72 (1.45) | < 0.001* |
| HGB, mean (SE), g/L | 122.28 (1.67) | 127.83 (1.59) | 0.209 | 125.46 (1.54) | 127.17 (2.60) | 0.385 |
| GLU, mean (SE), mmol/L | 5.56 (0.07) | 5.21 (0.13) | 0.010* | 5.80 (0.15) | 5.28 (0.08) | 0.010* |
| TBIL, mean (SE), umol/L | 17.18 (3.83) | 13.02 (0.59) | 0.354 | 14.52 (0.69) | 14.86 (0.89) | 0.341 |
| DBIL, mean (SE), umol/L | 4.66 (0.91) | 3.11 (0.13) | 0.001 | 4.30 (0.35) | 3.74 (0.34) | 0.435 |
| IBIL, mean (SE), umol/L | 13.56 (3.95) | 9.91 (0.49) | 0.935 | 10.22 (0.45) | 11.17 (0.70) | 0.115 |
| ALP, mean (SE), U/L | 84.49 (1.50) | 76.13 (2.40) | 0.001* | 85.06 (3.36) | 75.84 (3.64) | 0.153 |
| UA, mean (SE), umol/L | 301.77 (4.69) | 305.54 (8.48) | 0.851 | 307.97 (8.39) | 296.66 (10.19) | 0.351 |
| Ca, mean (SE), mmol/L | 2.64 (0.34) | 2.34 (0.01) | 0.001 | 2.29 (0.01) | 2.33 (0.02) | 0.049* |
| Mg, mean (SE), mmol/L | 1.06 (0.01) | 1.04 (0.02) | 0.968 | 1.07 (0.02) | 1.01 (0.02) | 0.062 |
| P, mean (SE), mmol/L | 1.09 (0.01) | 1.13 (0.02) | 0.047* | 1.09 (0.01) | 1.10 (0.02) | 0.858 |
| HCY, mean (SE), umol/L | 14.83 (0.58) | 11.48 (0.50) | < 0.001* | 14.90 (0.86) | 12.83 (0.71) | 0.252 |
P value is derived from the univariable association analyses. Chi-Square was used to analyze the difference of categorical data (Gender), while the independent sample t-test or Mann–Whitney U test was used to analyze the difference of quantitative data (Age, HGB, GLU, TBIL, DBIL, IBIL, ALP, UA, Ca, Mg, P, HCY)
HGB hemoglobin, GLU glucose, TBIL total bilirubin, DBIL direct bilirubin, IBIL indirect bilirubin, ALP alkaline phosphatase, UA uric acid, Ca calcium, Mg magnesium, P phosphorus, HCY homocysteine, SE standard error
*P value < 0.05
Fig. 3Receive operating characteristic curve (ROC) for the radiomics model, clinical model and combined model in distinguishing osteoporosis and osteopenia. A The model comparison in the training cohort. B The model comparison in the test cohort
Diagnostic performance of clinical, radiomics and combined clinical-radiomic model
| Group | Model | Accuracy | Sensitivity | Specificity | PPV | NPV |
|---|---|---|---|---|---|---|
| Training | Clinics | 0.78 | 0.90 | 0.56 | 0.79 | 0.76 |
| Test | Clinics | 0.74 | 0.88 | 0.51 | 0.74 | 0.72 |
| Training | Radiomics | 0.90 | 0.93 | 0.89 | 0.76 | 0.97 |
| Test | Radiomics | 0.94 | 0.92 | 0.95 | 0.86 | 0.97 |
| Training | Combined clinical-radiomics | 0.89 | 0.99 | 0.72 | 0.87 | 0.96 |
| Test | Combined clinical-radiomics | 0.90 | 0.98 | 0.75 | 0.88 | 0.96 |
PPV positive predictive value, NPV negative predictive value
Fig. 4Development and performance of nomogram. A Nomogram based on radiomics signatures and clinical factors. B Calibration curves of the radiomics nomogram in the training cohort. C Calibration curves of the radiomics nomogram in the test cohorts
Fig. 5Decision curve analysis for radiomics nomogram and signature